 23andMe |
Acquired by nonprofit, Jul 2025; Bankruptcy, Mar 2025 |
| 4d Pharma |
Bankrupt Jun 2022; Acquired by SPAC via Reverse Merger Oct 2020 |
| 9 Meters Biopharma |
Bankrupt Jul 2023; fka Innovate Biopharmaceuticals, Merged with RDD Pharma Apr 2020 |
| AccelaPure |
Bankrupt 2007 |
| Accentia Biopharmaceuticals |
Bankrupt, 2013 |
| Aceragen |
Bankrupt, Jul 2023, Liquidating |
| AcerMed |
Bankrupt, 2007, bought by Ophthalmic Imaging Systems Jan 2008 |
| Achaogen |
Chapter 11 bankruptcy, Apr 2019 |
| Acorda Therapeutics |
Filing Chapter 11 Bankruptcy, Apr 2024 |
| Acorn Cardiovascular |
Liquidated May 2011 |
| ActinoDrug Pharmaceuticals |
Bankrupt |
| AcuNetx |
Bankrupt, shut down Nov 2012 |
| ADS Biotechnology |
Bankrupt 2014 |
| Advanced Tissue Sciences |
Liquidated Mar 2003 |
| Aeolus Pharmaceuticals |
Liquidated Mar 2018 |
| Affigen |
Liquidating Fall 2019 |
| Agennix |
Bankrupt and liquidated, May 2013 |
| AirXpanders |
Filing Chapter 7 Bankruptcy, Jul 2019 |
| Akesis LLC |
Bankrupt 2015 |
| Akesis Pharmaceuticals |
Bankrupt 2009, closed 2013 |
| Akorn |
Chapter 7 bankruptcy, Feb 2023 |
| Akubio |
Bankrupt Sep 2007 |
| Alizyme |
Bankrupt 2009 |
| Alliances Catalyst |
Liquidated |
| Ambrilia Biopharma |
Bankrupt 2011 |
| Anesiva |
Bankrupt 2010 |
| Angel Biotechnology |
Bankrupt, 2013 |
| AngioGenetics |
Bankrupt, Jun 2011 |
| Annidis |
Effectively bankrupt, Feb 2018 |
| Antara Biosciences |
Bankrupt 2007 |
| Anterion Therapeutics |
Bankrupt Feb 2012 |
| Apta Biosciences |
Auctioning off assets, Aug 2020 |
| Aradigm |
Filed Chapter 11 Bankruptcy, Feb 2019 |
| Aralez Pharmaceuticals |
Bankrupt, Aug 2018, selling all assets |
| Ardana Biosciences |
Bankrupt, Jul 2008 |
| Argolyn Bioscience |
Bankrupt, Shut Down Jul 2009 |
| Argos Therapeutics |
Relaunched as CoImmune 2019; Filed Chapter 11 Bankruptcy Dec 2018; fka Dendritix, fka Merix Bioscience |
| Arisyn Therapeutics |
Bankrupt, Dec 2012 |
| Artimplant |
Bankrupt, 2013 |
| Athenex |
Chapter 11 Bankruptcy, May 2023 |
| AtheroNova |
Chapter 11 Bankruptcy Mar 2015, Website gone Jun 2016 |
| Aureon Biosciences |
Insolvency Proceedings |
| Avadel Specialty Pharmaceuticals |
Filed chapter 11, Feb 2019, bought by Roivant Apr 2019 |
| Azeria Therapeutics |
Liquidating Dec 2020 |
| Azopharma |
Bankrupt, Apr 2010 |
| Azzur |
Facilities now Chrysalis, Consulting business sold to Eliquent after Bankruptcy, Mar 2025 |
| BacterioScan |
Chapter 11 Bankruptcy, Nov 2021 |
| Bakhu Pharma |
Bankrupt, location sold |
| Baudax Bio |
Chapter 11 Bankruptcy, Feb 2024; Spun out of Recro Pharma, Nov 2019 |
| Baxano Surgical |
Bankrupt, 2014, product bought by group that named themselves TranS1 |
| BBB Therapeutics |
Bankrupt 2015 |
| BIND Therapeutics |
Filed Chapter 11 bankruptcy, May 2016, Assets bought by Pfizer for $40M |
| Biocept |
Chapter 7 Bankruptcy, Oct 2023 |
| Biolex Therapeutics |
Bankruptcy Liquidation 2012 |
| Biotica |
Bankrupt. Assets sold May 2013 |
| BioTransplant Inc |
Bankrupt, 2003 |
| BioVest |
Bankrupt, restructured, twice, Was told by a spinout employee that Biovest is no longer operating (Jul 2016) |
| Bohai Pharmaceuticals |
Bankrupt, 2017 |
| Bresagen Ltd |
Bankrupt Jan 2004, Acquired by Hospira, Oct 2006 |
| Calmune |
Liquidated |
| Cambridge Endoscopic Devices |
Bankrupt Sep 2015, selling assets off |
| Cardima |
Bankrupt Dec 2010 |
| Cellnovo |
Bankrupt, Jul 2019 |
| Ceragenix Pharmaceuticals |
Bankruptcy |
| Chantilly BioPharma |
Bankrupt Jun 2014 |
| Civetta Therapeutics |
Bankrupt, Dec 2023 |
| Clarus Therapeutics |
Website down Apr 2024 - Jun 2024; Bankrupt Sep 2022 |
| Cline Scientific |
Bankrupt Aug 2024 |
| Clovis Oncology |
Liquidated, Jul 2023; Bankruptcy filing Dec 2022 |
| Codiak BioSciences |
Selling assets through chapter 11 bankruptcy, Mar 2023 |
| Cohera Medical |
Bankrupt, Oct 2018 |
| Commonwealth Biotechnologies |
Bankrupt, merged into HedgePath Pharmaceuticals |
| Companion Diagnostics |
Site gone Mar 2017; Entered bankruptcy Sep 2014; relocated from CT to IN in 2010 |
| ConjuChem |
Bankrupt 2011 |
| Cosmederm Bioscience |
Bankrupt, Oct 2017 |
| Creative Antibiotics |
Filed for bankruptcy, Jun 2013 |
| Cue Health |
Shut down May 2024 |
| Cyon Therapeutics |
Bankrupt, Dec 2017 |
| DelSite |
Bankrupt |
| Dextera Surgical |
Bankrupt, Assets sold to Aesculap, Feb 2018 |
| diaDexus |
Filed Chapter 7, Jun 2016 |
| DMK Pharmaceuticals |
Bankruptcy, Feb 2024; Merged with Adamis, May 2023 |
| Dynogen |
Bankrupt, seemingly winding down slowly |
| Encorium |
Bankrupt |
| Endo Pharmaceuticals |
Merged with Mallinckrodt, Nov 2025 to become Keenova/Par Health |
| Endovasc |
Bankrupt 2008 |
| eNeura |
Chapter 7 bankruptcy, Aug 2020 |
| Entelos |
Bankrupt |
| Enumeral Biomedical |
Evicted, out of money Aug 2017, filed bankruptcy Feb 2018 |
| Epirus Biopharmaceuticals |
Chapter 7 bankruptcy, Jul 2016 |
| Existence Genetics |
Bankrupt Dec 2012 |
| FIT Biotech |
Bankrupt Feb 2019 |
| Garnet BioTherapeutics |
Bankrupt May 2011 |
| Gelesis |
Chapter 7 bankruptcy, Nov 2023 |
| GenapSys |
Sale to Sequencing Health approved Sep 2022; Chapter 11 bankruptcy, Jul 2022 |
| Gene Express Inc |
bankrupt? |
| Gene Logic |
Bankrupt |
| Gene Signal |
Bankrupt, Apr 2021 |
| Glide Technologies |
Bankrupt, Aug 2017, assets bought by Enesi Pharma |
| GlySens |
Bankrupt Nov 2022 |
| Gordagen Pharmaceuticals |
Bankrupt, dissolved Oct 2017 |
| Gritstone Bio |
Website down Feb 2025; Bankruptcy, Oct 2024; fka Gritstone Oncology |
| Halt Medical |
Bankrupt, Jun 2017. Bought by Acessa Health. |
| Health Diagnostic Laboratory |
Bankrupt, Jun 2015 |
| Helicos Biosciences |
Chapter 11 Bankruptcy Nov 2012, Assets purchased by SeqLL |
| Helios Biosciences |
Bankrupt. Gone 2011. Assets seem to have been purchased by AventaCell BioMedical |
| Histogen |
Chapter 11 Bankruptcy plus wind down Apr 2024; Acquired Conatus Pharmaceuticals, Jun 2020 to go public |
| HTG Molecular Diagnostics |
Website down Feb 2025; Chapter 11 Bankruptcy, Jun 2023 |
| Humanigen |
Website down Apr 2024 - Jun 2024; Filed Bankruptcy Jan 2024; fka KaloBios; Emerged from Bankruptcy, Jul 2016 |
| Immune Pharmaceuticals |
Filed Chapter 11 Bankruptcy, Feb 2019 |
| Immunicon |
Bankrupt - Assets sold to Veridex, Jun 2008 |
| Impel Pharmaceuticals |
Bankrupt, sold to investors, Feb 2024 |
| Infinity Pharmaceuticals |
Chapter 11 Bankruptcy, Sep 2023 |
| Inspiration Biopharmaceuticals |
Bankrupt/Sold Hemophilia Assets, Site not active as of 01-20-14 |
| Insys Therapeutics |
Filed Chapter 11 bankruptcy, Jun 2019, website gone Apr 2020 |
| Integrated Nano-Technologies |
Bankrupt Mar 2023 |
| Intica Biomedical |
Bankrupt 2014 |
| Introgen Therapeutics |
Bankrupt 2008, executives reincarnated as MultiVir |
| InVivo Therapeutics |
Chapter 11 Bankruptcy, Feb 2024, winding down |
| Itherx |
Bankrupt, changed name to get out of paying debts, lost court case. Apparently gone. |
| KineMed |
Site gone Oct 2017; Filed Chapter 11 Bankruptcy May 2016 |
| Kiromic BioPharma |
Bankrupt, May 2025; fka Kiromic |
| LexaGene |
Chapter 7 bankruptcy, Feb 2023 |
| Lucira Health |
Assets acquired out of Chapter 11 Bankruptcy by Pfizer, Apr 2023, $36.4M; fka Diassess |
| MabVax Therapeutics |
Sold off assets to BioNTech in bankruptcy, May 2019 |
| Macrophage Pharma |
Bankruptcy, Feb 2022 |
| Mallinckrodt |
Merged with Endo, Nov 2025 to become Keenova/Par Health |
| Medipure Pharmaceuticals |
Bankrupt, May 2022 |
| Medrobiotics |
Bankrupt, May 2024 |
| Medrobotics |
Bankrupt Jun 2022 |
| Mekonos |
Bankrupt Jun 2024; Website down Oct 2024 |
| Mermaid Bio |
Liquidating, Sep 2025 |
| MicroGEM |
Bankrupt, assets acquired by MicroGEM Apr 2016 |
| Microislet |
Bankrupt 2008 |
| Microphage |
Bankrupt Jun 2013 |
| Mithra Pharmaceuticals |
Bankrupt Jun 2024, selling assets |
| Modern Biosciences |
Bankrupt, Jan 2024 |
| Mologen |
Liquidating, May 2020 |
| Multerra Bio |
Bankrupt May 2021 |
| MultiCell Technologies |
Effectively bankrupt, Mar 2018 |
| NAEJA Pharmaceuticals |
Bankrupt, 2016, came back as NAEJA-RGM, Apr 2017 |
| NephroGenex |
Filed Chapter 11 Bankruptcy, May 2016; Site gone Jul 2018 |
| Neurologix |
Bankrupt, Liquidation |
| NextGen Sciences |
Defaulted, sued by employees |
| Northfield Laboratories |
Bankrupt 2009 |
| Notable Labs |
Chapter 7 Bankruptcy, Oct 2024; Merged with VBL Therapeutics, Oct 2023 |
| Novan Therapeutics |
Bankrupt, Selling Assets Jul 2023 |
| Novum Pharma |
Bankrupt, Feb 2019 |
| NuOrtho Surgical |
Bankrupt, Feb 2015 |
| Nuvectra |
Filed Chapter 11 bankruptcy, Nov 2019 |
| Oakrum Pharma |
Website down Aug 2024; Chapter 11 Bankruptcy May 2023 |
| Omega Therapeutics |
Website gone May 2025; Bankrupt, Feb 2025 |
| OncoSec Medical |
Chapter 7 Bankruptcy, June 2023 |
| OPK Biotech |
Bankrupt/Folded, Apr 2014 |
| Orexigen Therapeutics |
Bankrupt Mar 2018, Assets sold to Nalpropion Pharmaceuticals, Apr 2018, $75M |
| Oscient Pharmaceuticals |
Bankrupt, Jul 2009 |
| Palmaz Scientific |
Bankrupt, 2016 |
| PathoGenetix |
Bankrupt Jul 2014, ceased operations, terminated almost all employees |
| PEAR Therapeutics |
Chapter 11 Bankruptcy, Apr 2023 |
| Pernix Therapeutics |
Filed Chapter 11 Bankruptcy, Feb 2019; reborn as Currax Pharmaceuticals |
| PhaseBio Pharmaceuticals |
Shut down Feb 2023; Bankruptcy filed Oct 2022, lead sold Jan 2023 |
| PhaseRx |
Bankrupt Dec 2018, sold to Roivant Sciences Feb 2018, $800K |
| Piqur Therapeutics |
Liquidating, Jun 2021 |
| PLx Pharma |
Bankrupt, winding down May 2023 |
| PolyMedix |
Bankrupt Apr 2013 |
| PRACS Institute |
Bankrupt 2013 |
| Protea Biosciences |
Website down Jul 2020 - Aug 2020; Bankrupt Dec 2017 |
| Provell Pharmaceuticals |
Bankrupt Apr 2025 |
| Regen Biologics |
Bankrupt, product sold to Stryker |
| Rock Creek Pharmaceuticals |
Chapter 7 Bankrupt, Sep 2016 |
| Rosetta Genomics |
Filed for Chapter 7 bankruptcy, Jun 2018 |
| Sancilio Pharmaceuticals |
Bankrupt, out of business May 2019, some assets bought by Micell Biopharma |
| Savient Pharmaceuticals |
Bankrupt, Oct 2013 |
| SemBioSys |
Bankrupt, Jul 2012 |
| Siena Biotech |
Bankrupt, Apr 2015 |
| Sienna Biopharmaceuticals |
Filed Chapter 11 bankruptcy, Sep 2019 |
| Spherics |
Bankrupt |
| Spiriplex |
Bankrupt, Mar 2023 |
| Statera Biopharma |
Bankrupt Jun 2022; went public via Reverse Merger with Cleveland BioLabs, Oct 2020 |
| StemGenex |
Filed Chapter 7 Bankrupt, Sep 2019 |
| Stimwave |
Bankrupt, Oct 2022 |
| Suir Pharma |
Bankrupt, May 2016 |
| Surgalign |
Chapter 11 Bankruptcy Jun 2023; fka RTI Surgical Holdings |
| Synergy Pharmaceuticals |
Acquired by Bausch Mar 2019; Bankrupt, Dec 2018, want to accept Bausch bid $200M for assets, auction forthcoming |
| TC Biopharm |
Bankruptcy, Nov 2025; Website down Oct 2025 - Dec 2025 |
| Tengion |
Went bankrupt, Mar 2015, bought by two former employees, seem to be rebranded as RegenMedTx |
| TheoremDx |
Bankrupt Feb 2020 |
| Tikcro Technologies |
Liquidating 2021 |
| Timber Pharmaceuticals |
Assets acquired by Leo Pharma, Jan 2024; Bankrupt |
| to-BBB |
Bankrupt, but may have come back as BBB Therapeutics |
| TorreyPines Therapeutics |
Bankrupt 2009, Assets transferred to Calicimedica |
| Transdel Pharmaceuticals |
Bankrupt, Jun 2011 |
| TransGenRx |
Bankrupt |
| Traversa Therapeutics |
Bankrupt |
| Tricida |
Liquidating May 2023; Chapter 11 bankruptcy, Jan 2023 |
| Trion Pharma |
Insolvent, technology acquired by Lindis Biotech |
| uBiome |
Chapter 11 Bankruptcy, Sep 2019 |
| Unilife |
Bankrupt, Apr 2017 |
| Velicept Therapeutics |
Trying to find a buyer for company/IP Dec 2020; Website down Jan 2021 - Apr 2021 |
| ViewRay |
Shut down Oct 2023; Chapter 11 Bankruptcy, Jul 2023 |
| Vion Pharmaceuticals |
Bankrupt, defunct 2010 |
| Viropro |
Bankrupt 2015 |
| Vyaire Medical |
Website down Jun 2025; Filed Chapter 11 Bankruptcy, Jun 2024; Spun out of CareFusion Oct 2016 |
| Vyera Pharmaceuticals |
Website gone Oct 2024; Chapter 11 bankruptcy, May 2023; fka Turing Pharmaceuticals; Legally named Phoenixus |
| Vyteris |
Bankrupt 2012 |
| XNK Therapeutics |
Bankrupt, Assets sold May 2024 |
| Znomics |
Bankrupt, Shell Company Now |
| Zosano Pharma |
Acquired by Emergex out of Chapter 11 bankruptcy Aug 2022, $1M |
